AC
AFIB

Aristides Capital’s Acutus Medical Inc AFIB Stock Holding History

Aristides Capital’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-38,374
Closed -$131K – 309
2021
Q4 		$131K Buy
+38,374
New +$216K 0.06% 227

Other funds holding AFIB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $183M AUM 2.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Aristides Capital's AFIB Position: Q1 2022 in Review

Aristides Capital sold out of Acutus Medical Inc (AFIB) in Q1 2022, closing a stake of 38,374 shares — an estimated $131K sold.

Aristides Capital first reported a position in AFIB in Q4 2021 and held it in 1 quarter. The position peaked at $131K in Q4 2021. 65 funds tracked by Wall St. Rank hold AFIB as of Q1 2022.

  • Aristides Capital reported no remaining Acutus Medical Inc position as of Q1 2022 after selling out during the quarter.
  • Aristides Capital sold 38,374 Acutus Medical Inc shares in Q1 2022, an estimated $131K.
  • Aristides Capital first reported a position in Acutus Medical Inc in Q4 2021 and held it in 1 quarter.
  • Aristides Capital's Acutus Medical Inc position peaked at $131K in Q4 2021.
  • 65 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q1 2022.

Based on Aristides Capital's 13F filing for Q1 2022, filed 16 May 2022.